UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A volatility index measures fear, while an equity index tracks stock performance. This explanation clarifies their distinct roles for investors.
21,928 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
As market conditions shift in March 2026, traders seek better tools and pricing. This guide highlights the best SoFi ...
Rival AI employees have filed an amicus brief backing Anthropic in a Pentagon-led dispute over a supply-chain risk de...
March 2026 brings a wave of Koyfin alternatives as traders seek deeper data, faster alerts, and cleaner interfaces. H...
Kalshi launches its Brazil prediction market through XP International, reframing macro bets as regulated derivatives....
Discover how to read Infinity Natural's earnings calls like a pro. This guide explains the metrics to watch, how mana...
Investors wonder whether Intuitive Surgical stock is worth the risk in today’s market. This comprehensive guide weigh...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
A major investor liquidated a sizable stake as the decking stock down 35% over the past year. This article breaks dow...
The 2026 Social Security COLA is 2.8%, but higher-income retirees face loss due to Medicare IRMAA surcharges that swa...